| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11021976 | American Journal of Ophthalmology | 2018 | 25 Pages |
Abstract
Latanoprost had an acceptable safety profile with no evidence of inducing clinically meaningful or statistically significant changes in ocular development or ocular hyperpigmentation in pediatric patients with glaucoma and ocular hypertension.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Muhammad Younus, Ronald A. Schachar, Min Zhang, Marla B. Sultan, Charles S. Tressler, Kui Huang, Wanning Xu, Mitchel Klein, Robert W. Platt, Nandita Mukherjee, Estelle Haenel, Sharon F. Freedman,